Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in 2026

European Healthtech startup funding raised during 2026.

In 2026, 372 European Healthtech companies closed 390 funding rounds and raised €12B in equity funding (excluding debt and grants). Debt rounds added €510M. UK led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 20 Nov 2026.

Equity funding
€12B
excl. debt & grants · +€510M debt
Funding rounds
390
Companies
372
Top country
UK

Healthtech: last three years

2026 is to date; no change shown against a full year
YearEquityChangeRoundsChangeDebt
2024€5.1B-29.0%425-20.6%€83M
2025€7.5B+47.0%439+3.3%€146M
2026 (to date)€12B—390—€510M
Break down 2026 by period
in progress — period is still running
Rank among sectors
#3
12.8% of sector funding
Debt financing
€510M
4.2% of total
Top-10 round share
67.1%
of disclosed capital
Rounds ≥ €100M
11

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, 2026 — interactive chart.
Data table
FundingRounds
Jan€850M51
Feb€446M40
Mar€279M42
Apr€253M35
May€2.0B33
Jun€486M36
Jul€812M31
Aug€245M20
Sep€833M38
Oct€1.3B32
Nov€4.8B32

Top countries

by € raised
Healthtech — top countries by capital, 2026 — interactive chart.
Data table
Healthtech — top countries by capital, 2026
UK€8.4B
Sweden€899M
France€660M
Switzerland€532M
Germany€410M
Spain€349M
Netherlands€250M
Denmark€157M

Stage mix

by € raised
Healthtech — stage mix, 2026 — interactive chart.
Data table
Healthtech — stage mix, 2026
Series C€5.9B
Series B€2.5B
Other€1.4B
Series A€737M
Debt€510M
Growth/Late€448M
Seed€365M
Series D+€320M
Grant€70M
Pre-Seed€48M
Crowdfunding€233k

Exits & M&A

24 Acquisition

24 exits · €1.0B disclosed.

Saga DiagnosticsAcquisitionApr 2026€504M
Kaia HealthAcquisitionJan 2026€239M
GleamerAcquisitionMar 2026€230M

Largest equity rounds

by disclosed amount, 2026
CompanyStageDateAmount
Isomorphic LabsSeries CNov 2026€4.6B
Isomorphic LabsSeries BMay 2026€1.8B
Neko HealthSeries CJul 2026€614M
CMR SurgicalGrowth/LateOct 2026€355M
OMass TherapeuticsSeries COct 2026€273M
OvivaSeries D+Jan 2026€200M
Basecamp ResearchSeries CSep 2026€123M
NouscomSeries BOct 2026€120M
CeQurSeries D+Jun 2026€86M
HighLifeOtherSep 2026€80M

Largest debt rounds

debt financing, 2026; not in the equity total
CompanyStageDateAmount
Scan.comDebtSep 2026€112M
AlvotechDebtJan 2026€100M
ElektaDebtAug 2026€100M
DistalMotionDebtOct 2026€63M
TissiumDebtJun 2026€30M

Top investors

most active in 2026, by deal count

Source: Tech.eu Funding Explorer · data as of 20 Nov 2026 · licence CC BY 4.0 · Methodology